Galmed Pharmaceuticals Financial Overview
Galmed Pharmaceuticals's market cap is currently $4.66M. The company's EPS TTM is $-0.33; its P/E ratio is -0.26; Galmed Pharmaceuticals is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
